Our results demonstrate that improved GCK expression in β-cells restores glucose-stimulated insulin secretion (GSIS), lowers fasting blood glucose and improves glucose tolerance in a mouse model of HFD-induced diabetes, indicating a crucial role of impaired β-cell GCK expression in diet-induced diabetes. The gene discussed is GCK; the disease is diabetes mellitus.